Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

Core Viewpoint - Co-Diagnostics, Inc. is set to release its fourth quarter and full year 2024 financial results on March 27, 2025, after market close, followed by a conference call to discuss these results with analysts [1]. Company Overview - Co-Diagnostics, Inc. is a molecular diagnostics company based in Utah, specializing in the development, manufacturing, and marketing of advanced diagnostic technologies [3]. - The company's technologies focus on tests that detect and analyze nucleic acid molecules (DNA or RNA) and include proprietary designs for its Co-Dx PCR at-home and point-of-care platform [3].